Breakthrough malaria drug likely by ’18
Breakthrough malaria drug likely by ’18 (Getty Images) Contrary to the perception that drug research is mostly focused around the diseases of the elite, the antimalarial drug pipeline has increased nearly three-fold since 2008, with at least three new medicines expected to be launched in two to five years. India, where a lot of clinical trials have already begun, is likely to get a breakthrough anti-malarial drug Tafenoquine by 2018. The drug, a one-day-two-dose treatment, has already entered phase-three trials and once approved will replace the current 14-day treatment for…
Read More